CG
PRAH

Caprock Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Caprock Group’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,000
Closed -$221K – 416
2019
Q1 		$221K Sell
2,000
-360
-15% -$37.6K 0.04% 326
2018
Q4 		$217K Hold
2,360
– – 0.05% 298
2018
Q3 		$260K Hold
2,360
– – 0.05% 305
2018
Q2 		$220K Sell
2,360
-390
-14% -$33.6K 0.05% 367
2018
Q1 		$228K Hold
2,750
– – 0.05% 357
2017
Q4 		$248K Sell
2,750
-25
-0.9% -$2.08K 0.05% 361
2017
Q3 		$211K Hold
2,775
– – 0.04% 397
2017
Q2 		$208K Buy
+2,775
New +$192K 0.05% 378

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Caprock Group's PRAH Position: Q2 2019 in Review

Caprock Group sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2019, closing a stake of 2,000 shares — an estimated $221K sold.

Caprock Group first reported a position in PRAH in Q2 2017 and held it in 8 quarters. The position peaked at $260K in Q3 2018. 329 funds tracked by Wall St. Rank hold PRAH as of Q2 2019.

  • Caprock Group reported no remaining PRA Health Sciences, Inc. position as of Q2 2019 after selling out during the quarter.
  • Caprock Group sold 2,000 PRA Health Sciences, Inc. shares in Q2 2019, an estimated $221K.
  • Caprock Group first reported a position in PRA Health Sciences, Inc. in Q2 2017 and held it in 8 quarters.
  • Caprock Group's PRA Health Sciences, Inc. position peaked at $260K in Q3 2018.
  • 329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2019.

Based on Caprock Group's 13F filing for Q2 2019, filed 23 Jul 2019.